[1] Siegel RL,Miller KD,Jemal A. Cancer statistics,2017[J]. CA Cancer J Clin,2017,67(1):7-30.
[2] Miller KD,Siegel RL,Lin CC,et al. Cancer treatment and survivorship statistics,2016[J]. CA Cancer J Clin,2016,66(4):271-289.
[3] 王正航,周军,沈琳. 胰腺癌药物治疗的现状与困境[J]. 中华肿瘤杂志,2017,39(9):712-716.
[4] Voets T,Droogmans G,Wissenbach U,et al. The principle of temperature-dependent gating in cold-and heat-sensitive TRP channels[J]. Nature,2004,430(7001):748-754.
[5] Kym PR,Kort ME,Hutchins CW. Analgesic potential of TRPV1 antagonists[J]. Biochem Pharmacol,2009,78(3):211-216.
[6] Wong GY,Gavva NR. Therapeutic potential of vanilloid receptor TRPV1 agonists and antagonists as analgesics:Recent advances and setbacks[J]. Brain Res Rev,2009,60(1):267-277.
[7] Prevarskaya N,Zhang L,Barritt G. TRP channels in cancer[J]. Biochim Biophys Acta, 2007,1772(8):937-946.
[8] Drewes AM,Krarup AL,Detlefsen S,et al. Pain in chronic pancreatitis:the role of neuropathic pain mechanisms[J]. Gut,2008,57(11):1616-1627.
[9] Zheng L,Chen J,Ma Z,et al. Capsaicin enhances anti-proliferation efficacy of pirarubicin via activating TRPV1 and inhibiting PCNA nuclear translocation in 5637 cells[J]. Mol Med Rep,2016,13(1):881-887.
[10] Wu TT,Peters AA,Tan PT,et al. Consequences of activating the calcium-permeable ion channel TRPV1 in breast cancer cells with regulated TRPV1 expression[J]. Cell Calcium,2014,56(2):59-67.
[11] Miao X,Liu G,Xu X,et al. High expression of vanilloid receptor-1 is associated with better prognosis of patients with hepatocellular carcinoma[J]. Cancer Genet Cytogenet,2008,186(1):25-32.
[12] Lazzeri M,Vannucchi MG,Spinelli M,et al. Transient receptor potential vanilloid type 1(TRPV1) expression changes from normal urothelium to transitional cell carcinoma of human bladder[J]. Eur Urol,2005,48(4):691-698.
[13] Bode AM, Cho YY, Zheng D,et al. Transient receptor potential type vanilloid 1 suppresses skin carcinogenesis[J].Cancer Res,2009,69(3):905-913.